FDA Inspection 829992 — Stephan A. Grupp, M.D., Ph.D.
The FDA completed an inspection of Stephan A. Grupp, M.D., Ph.D. on May 2, 2013 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 2, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Philadelphia, PA (United States)
Additional Details
Clinical Investigator (CI)